CAS 1246819-27-1

Imatinib para-diaminomethylbenzene impurity-d3

CAS : 1246819-27-1

Imatinib is a small molecule drug that binds to the ATP-binding site of tyrosine kinase and inhibits the activity of protein tyrosine kinases. Imatinib is used for the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). Imatinib impurity D3 is a by-product formed during synthesis, which can be removed by purification. The purity level of imatinib is 99.5% or greater, with an impurity level of less than 0.5%.

Formule : C₂₉H₃₂N₇O

Degré de pureté : Min. 95%

Masse moléculaire : 497.6 g/mol

Ref: 3D-WZB81927